retinal vein occlusion (rvo) is a common retinal vascular occlusive disorder and is associated with a variety of systemic risk factors. the aim of this study was to investigate whether the underlying diseases were evaluated and managed appropriately by ophthalmologists. we performed a study of 1344 patients with retinal vein occlusion (rvo). patients were evaluated with a questionnaire includin...

OBJECTIVE To investigate a possible association between retinal vein occlusion (RVO) and an increased risk of developing acute myocardial infarction (AMI). DESIGN A population-based retrospective cohort study using the entire population of the Taiwan National Health Insurance Research Database (NHIRD) from 1st January, 2001 to 31st December, 2013. METHODS A total of 37921 subjects with RVO ...

Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO). A basic risk factor for RVO is advancing age. Further risk factors include systemic conditions like hypertension, arteriosclerosis, diabetes mellitus, hyperlipidemia, vascular cerebral stroke, ...

purpose: to compare the effect of tissue plasminogen activator (tpa) and aspirin in patients with central retinal vein occlusion. methods: a prospective interventional study was conducted on patients with central retinal vein occlusion of less than 28 days' duration. patients in the tpa group received 100 μg intravitreal tissue plasminogen activator and the patients who declined intravitre...

PURPOSE The purpose of the study was to assess if a scanning laser ophthalmoscope (SLO), Optomap 200Tx, could be used for measurements of hemoglobin oxygen saturation in retinal blood vessels. METHODS Optomap 200Tx uses two lasers for image acquisition, 532 and 633 nm. Retinal images of healthy individuals and patients with retinal vein occlusion were analyzed with modified Oxymap Analyzer so...

•From baseline to week 76, 65.6% of patients gained ?15 letters.•In the treat-and-extend phase, 45.0% achieved a mean treatment interval ?8 weeks.•A last actual weeks was by 63.1% patients.•Mean BCVA 51.9 letters at and 72.3 76 (+20.3 letters).•Mean central retinal thickness decreased from 759.9 µm 265.4 (?496.1 µm). PurposeTo evaluate efficacy safety intravitreal aflibercept (IVT-AFL) dosing i...

PURPOSE This study investigates the differential aqueous concentrations of interleukin 6, 8, 1β (IL-6, IL-8, IL-1β, respectively), serum amyloid A (SAA), transforming growth factor (TGF)-β, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) in eyes with macular edema as a result of a branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO)....

PURPOSE To evaluate how the growth of neovascularization elsewhere (NVE) was delineated in an eye with hemicentral retinal vein occlusion (CRVO) using optical coherence tomography (OCT) angiography. PATIENTS AND METHODS We examined a 64-year-old man diagnosed with hemi-CRVO. The area around the occluded vein was scanned using a spectral-domain OCT device (RTVue XR Avanti). Blood flow was dete...